Yunnan Hansu Biotechnology Co.,Ltd (“Hansu”) accessed to title of China Hi-tech SMEs of Yunnan province according to “Hi-tech SMEs Principles” ( 2017 No. 115) & “Hi-tech SMEs Guidelines”(2017 No. 144) and other relevant provisions.
Hansu was located in Yunnan as a key project of Ministry of Science and Technology recommending “S&T in Yunnan”. Hansu passed various administrative unit and provincial public security department and obtained “Industrial Hemp Flower Leaf Processing License” which constructed a large single CBD and other cannabinoid extraction factory. Hansu can extract variety of active ingredients that do not contain psychoactive substances that is the factory can extract Cannflavin A.
Hansu has been maintaining a steady flow of endogenous power in the aspects of innovative resource mining, innovative technology development and innovative industrial application. It is equipped with a key scientific research laboratory and a Chinese academician workstation committed to forward-looking R&D in global extraction field. R&D center has multiple professional research platforms, such as diversified preparation development platform, plant separation technology platform and so on. At present, it has mastered a number of core intellectual property rights promoting enterprises to take the a leading in science and technology.
Hansu has obtained the capital injection of hemp industry fund leading by Ministry of Science and Technology with large central enterprises and state-owned enterprises LP and Tsinghua Qixing started the phase II project of Hansu as the fund manager. The project named Yunnan Hempmon Pharmaceutical Co., Ltd. (” Hempmon”). Hansu became as the shareholder of KRB Company with its technology which made the preparation technology of bio-pharmaceutical internationalized.
Hansu will strengthen its scientific research in key industry and technology to create innovative technology and extract health elements for life.